<Anchor> The
FDA advisory group, which has the highest authority on vaccines in the United States, put the brakes on the third dose of Pfizer's vaccine for COVID-19. It is said that safety has not been sufficiently proven, and it seems inevitable that the US government's plan to give booster vaccinations from next week will be disrupted.
Correspondent Kang Cheong-wan.
<Reporter> The
U.S. Food and Drug Administration's FDA Vaccine Advisory Committee said that it had strongly opposed the third dose of Pfizer's vaccine as a result of the meeting.
In the vote in which 18 experts participated, the dissenting opinion was overwhelming with 16 against and 2 in favor.
Experts cited as the objection that there is still not enough data on the safety of the third dose, or booster shot.
[Phil Kraus / US Food and Drug Administration (FDA) Vaccines Tribunal busiljang: This is one of the problems is that a lot of data will be discussed in connection with the third corona 19 vaccination did not review other professionals or FDA]
of Israel, which already carried the third vaccination It was also noted that the relevant data were not adequate to predict the situation in the United States, and that the need for additional vaccinations was not evident for everyone, but not some high-risk groups.
This decision is a recommendation and is not legally binding.
However, as it is the conclusion of the advisory group with the highest authority on the coronavirus vaccine, the Joe Biden administration's plan to start the third dose starting next week is likely to be disrupted.
The New York Times and other US media predicted that the FDA would make a final decision early next week.